MDGL R&D Expenses
Madrigal Pharmaceuticals Inc · R&D Expenses
MDGL R&D Expenses
Latest reported$490.14Mperiod ending
MDGL R&D Expenses ($277.00K → $490.14M)
Annual R&D Expenses
High-resolution chart · PNG
MDGL r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 388,525,000 | |
| 236,718,000 | |
| 272,350,000 | |
| 245,441,000 | |
| 205,164,000 | |
| 184,809,000 | |
| 72,324,000 | |
| 25,389,000 | |
| 24,390,000 | |
| 15,934,000 | |
| 54,218,000 | |
| 68,205,000 | |
| 71,860,000 | |
| 49,412,000 | |
| 41,464,000 | |
| 40,252,000 | |
| 51,054,000 | |
| 81,581,000 | |
| 52,025,000 | |
| 50,503,000 | |
| 59,901,000 | |
| 38,136,000 | |
| 24,337,000 | |
| 7,292,000 | |
| 277,000 |